The FDA has granted tentative approval for Lupin's drug application, noting its bioequivalence to Astellas' reference drug.
1 report, 1 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has granted tentative approval for Lupin's drug application, noting its bioequivalence to Astellas' reference drug.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United States Food and Drug Administration
agency of the US Department of Health and Human Services